Christopher R Ensor

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Induction immunosuppression for orthotopic heart transplantation: a review
    Christopher R Ensor
    Comprehensive Transplant Center, Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Prog Transplant 19:333-41; quiz 342. 2009
  2. ncbi Proliferation signal inhibitor toxicities after thoracic transplantation
    Christopher R Ensor
    University of Maryland School of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, Department of Pharmacy Practice and Science, Baltimore MD 21287 6180, USA
    Expert Opin Drug Metab Toxicol 9:63-77. 2013
  3. ncbi Antithrombotic therapy for the CardioWest temporary total artificial heart
    Christopher R Ensor
    Department of Pharmacy, Comprehensive Transplant Center, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Tex Heart Inst J 37:149-58. 2010
  4. ncbi Pharmacotherapy for mechanical circulatory support: a comprehensive review
    Christopher R Ensor
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 45:60-77. 2011
  5. ncbi Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system
    Christopher R Ensor
    Department of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287 6180, USA
    Prog Transplant 21:121-3. 2011
  6. ncbi Generic maintenance immunosuppression in solid organ transplant recipients
    Christopher R Ensor
    Comprehensive Transplant Center, The Johns Hopkins Hospital, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacotherapy 31:1111-29. 2011
  7. ncbi Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Jessica C Wellman
    Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am J Health Syst Pharm 68:934-9. 2011
  8. ncbi Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012

Detail Information

Publications8

  1. ncbi Induction immunosuppression for orthotopic heart transplantation: a review
    Christopher R Ensor
    Comprehensive Transplant Center, Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Prog Transplant 19:333-41; quiz 342. 2009
    ..To describe the appropriateness and safety of induction immunosuppression for patients at risk for fatal rejection, and to describe the safety and effectiveness profiles of the induction regimens available in the United States...
  2. ncbi Proliferation signal inhibitor toxicities after thoracic transplantation
    Christopher R Ensor
    University of Maryland School of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, Department of Pharmacy Practice and Science, Baltimore MD 21287 6180, USA
    Expert Opin Drug Metab Toxicol 9:63-77. 2013
    ..It is critical that patients be wisely selected for PSI use in an effort to minimize toxicities...
  3. ncbi Antithrombotic therapy for the CardioWest temporary total artificial heart
    Christopher R Ensor
    Department of Pharmacy, Comprehensive Transplant Center, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Tex Heart Inst J 37:149-58. 2010
    ..The development and monitoring of individualized antithrombotic regimens require that informed health professionals appreciate the complexities and grasp the hazards that are associated with these therapies...
  4. ncbi Pharmacotherapy for mechanical circulatory support: a comprehensive review
    Christopher R Ensor
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 45:60-77. 2011
    ....
  5. ncbi Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system
    Christopher R Ensor
    Department of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287 6180, USA
    Prog Transplant 21:121-3. 2011
    ..He improved after administration of broad-spectrum antibiotics, which were narrowed to ampicillin/sulbactam for a prolonged 6-week course, and subsequently recovered fully...
  6. ncbi Generic maintenance immunosuppression in solid organ transplant recipients
    Christopher R Ensor
    Comprehensive Transplant Center, The Johns Hopkins Hospital, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacotherapy 31:1111-29. 2011
    ....
  7. ncbi Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Jessica C Wellman
    Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am J Health Syst Pharm 68:934-9. 2011
    ..CONCLUSION. Case-based advanced training and implementation of an IAP in a tertiary care hospital increased pharmacists' involvement in the management of inpatients receiving anticoagulants...
  8. ncbi Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012
    ..To review the literature regarding current strategies and strategies under active development for the prevention and treatment of respiratory syncytial virus (RSV) infections in immunocompromised adults...